Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4468477
Max Phase: Preclinical
Molecular Formula: C53H85N3O15
Molecular Weight: 1004.27
Molecule Type: Unknown
Associated Items:
ID: ALA4468477
Max Phase: Preclinical
Molecular Formula: C53H85N3O15
Molecular Weight: 1004.27
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]2O)[C@@H](CC(C(=O)NC(C)(C)C)N(CC)C(=O)c2ccccc2)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@H]1O[C@@H](C)[C@H](O)[C@H](OC)[C@@H]1OC
Standard InChI: InChI=1S/C53H85N3O15/c1-15-40-36(28-67-52-48(66-14)47(65-13)44(61)33(7)69-52)24-29(3)22-23-38(57)30(4)25-35(26-37(49(63)54-53(8,9)10)56(16-2)50(64)34-20-18-17-19-21-34)46(31(5)39(58)27-41(59)70-40)71-51-45(62)42(55(11)12)43(60)32(6)68-51/h17-24,30-33,35-37,39-40,42-48,51-52,58,60-62H,15-16,25-28H2,1-14H3,(H,54,63)/b23-22+,29-24+/t30-,31+,32-,33+,35-,36-,37?,39-,40-,42+,43-,44+,45-,46-,47+,48+,51+,52+/m1/s1
Standard InChI Key: FEKVBHAHCBEGGG-KPBNMUSSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1004.27 | Molecular Weight (Monoisotopic): 1003.5981 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Budragchaa T, Westermann B, Wessjohann LA.. (2019) Multicomponent synthesis of α-acylamino and α-acyloxy amide derivatives of desmycosin and their activity against gram-negative bacteria., 27 (15): [PMID:31229422] [10.1016/j.bmc.2019.05.046] |
Source(1):